LeMaitre Vascular Acquires Artegraft
June 22, 2020
LeMaitre Vascular, Inc. acquired the business and assets of Artegraft, Inc. for $90.0 million (including $72.5 million at closing and up to $17.5 million in earnouts). The acquisition adds Artegraft's biologic vascular graft product line (used primarily for hemodialysis access) to LeMaitre's portfolio and will keep Artegraft's North Brunswick, New Jersey manufacturing facility and most employees in place.
- Buyers
- LeMaitre Vascular, Inc.
- Targets
- Artegraft, Inc.
- Sellers
- Artegraft, Inc.
- Industry
- Medical Devices
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Medtronic to Acquire Scientia Vascular
March 10, 2026
Medical Devices
Medtronic entered into a definitive agreement to acquire Scientia Vascular in a $550 million deal, with customary adjustments and potential earn-out/milestone payments. The acquisition combines Scientia’s neurovascular access devices (guidewires and catheters) with Medtronic’s existing neurovascular therapeutic portfolio to support faster and more reliable treatment for complex stroke cases.
-
Solventum Completes Acquisition of Acera Surgical
December 23, 2025
Healthcare Services
Solventum completed its acquisition of Acera Surgical, a privately held bioscience company focused on regenerative wound care. The deal includes $725 million in upfront cash plus up to $125 million in contingent cash payments tied to future milestones.
-
Arterex Acquires Adroit USA Inc.
February 3, 2025
Medical Devices
Arterex has acquired Adroit USA Inc., a vertically integrated medical device contract manufacturer with facilities in Bangalore, India and a U.S. engineering lab in Milpitas, California. The deal adds over 650 employees and expanded injection molding, precision metal fabrication and assembly capabilities, strengthening Arterex’s global manufacturing footprint and offering an alternative production source to China.
-
BioVentrix Acquires MateraCor, Inc.
January 27, 2022
Medical Devices
BioVentrix, a privately held medical device company focused on less invasive left-ventricle therapies, has acquired MateraCor, Inc., a Southern California start-up developing an injectable alginate-based hydrogel and delivery system (TCMR) to prevent and reverse heart failure. The deal expands BioVentrix’s product portfolio for left ventricular restoration and adds development expertise as the company builds a platform of complementary heart-failure therapies.
-
Lectra to Acquire Gerber Technology
February 8, 2021
Industrial Services
Lectra entered into a Memorandum of Understanding to acquire all capital and voting rights of US-based Gerber Technology, subject to work council consultation, merger control clearance and shareholder approval. The proposed deal envisages an upfront cash-free / debt-free payment of €175 million plus 5 million newly issued Lectra shares to AIPCF VI LG (an affiliate of American Industrial Partners), representing a total consideration of about €300 million based on Lectra's Feb 5, 2021 share price; Gerber reported €165 million of revenue in 2020.
-
Integra LifeSciences Acquires ACell, Inc.
December 16, 2020
Medical Devices
Integra LifeSciences agreed to acquire regenerative-medicine company ACell, Inc. for $300 million upfront in cash plus up to $100 million in revenue-based milestones. The acquisition adds ACell's MatriStem porcine urinary bladder matrix platform to Integra's tissue technologies portfolio and is expected to close in Q1 2021, subject to customary conditions.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.